Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2026-01-24 @ 3:50 PM
Study NCT ID:
NCT01302795
Status:
COMPLETED
Last Update Posted:
2016-09-27
First Post:
2011-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Canakinumab for Pyoderma Gangrenosum
Sponsor:
University of Zurich
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DER-USZ-AAN-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None